Quick Answer
Arcus Biosciences, Inc. reported Total Revenue of $247.00 million for fiscal year 2025.
Arcus Biosciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $247.00M | -4.3% |
| 2024 | $258.00M | +120.5% |
| 2023 | $117.00M | +4.5% |
| 2022 | $112.00M | -70.8% |
| 2021 | $383.00M | +391.0% |
| 2020 | $78.00M | +420.0% |
| 2019 | $15.00M | +79.6% |
| 2018 | $8.35M | +491.2% |
| 2017 | $1.41M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.00M | -45.8% | -83.8% |
| June 30, 2025 | $160.00M | +310.3% | +471.4% |
| March 31, 2025 | $28.00M | -80.7% | -41.7% |
| September 30, 2024 | $48.00M | +50.0% | +23.1% |
| June 30, 2024 | $39.00M | +34.5% | -73.1% |
| March 31, 2024 | $145.00M | +480.0% | +353.1% |
| September 30, 2023 | $32.00M | -3.0% | +10.3% |
| June 30, 2023 | $29.00M | +7.4% | +16.0% |
- Arcus Biosciences, Inc. showed a decrease of -4.3% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, Arcus Biosciences, Inc.’s total revenue has grown by 17380.5% (from $1.41 million to $247.00 million).
- The most recent figure is from Arcus Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: